Tech & Pharma

Baiyunshan Gets CFDA Approval For Generic Viagra Baiyunshan Gets CFDA Approval For Generic Viagra
  • September 30th, 2014
  • The approval of Baiyunshan’s generic Viagra could help it attain market dominance in China’s erectile dysfunction sector.

» Read More...

Tech & Pharma

Baiyunshan Gets CFDA Approval For Generic Viagra

Baiyunshan Gets CFDA Approval For Generic Viagra

The approval of Baiyunshan’s generic Viagra could help it attain market dominance in China’s erectile dysfunction sector.

Mead Johnson Opens US$325 Million Facility In Singapore

Mead Johnson Opens US$325 Million Facility In Singapore

Seeking to stay close to the growing Asian pediatric nutrition market, Mead Johnson opens a new manufacturing and research facility in Singapore.

Keeping Li-S In Its Place

Keeping Li-S In Its Place

Researchers have developed a method of containing Li-S, paving the way for more compact rechargeable batteries.

First Drug For Dementia With Lewy Bodies Approved

First Drug For Dementia With Lewy Bodies Approved

Eisai’s Aricept® is the world’s first treatment indicated for both Alzheimer’s and dementia with Lewy bodies.

Floating Solar Farms For India and Japan

Floating Solar Farms For India and Japan

Companies in Japan and India have started utilizing floating power farms to circumvent the lack of space on land.

ASLAN Commences Taiwan Trials For Gastric Cancer Drug

ASLAN Commences Taiwan Trials For Gastric Cancer Drug

ASLAN has begun treating its first gastric cancer patients in Taiwan, where 4,000 people are affected by the disease annually.

ToolGen & KAIST To Collaborate On Biofuel Gene Editing

ToolGen & KAIST To Collaborate On Biofuel Gene Editing

KAIST partners gene editing company ToolGen to develop methods of increasing biofuel yield from microalgae.

Biocon Runs Free Oral Cancer Screens In India

Biocon Runs Free Oral Cancer Screens In India

Biocon organized a week of free oral cancer screening activities across 23 Indian cities from September 1-7, 2014.

Luye Acquires Jialin for US$600 Million

Luye Acquires Jialin for US$600 Million

Luye Pharma strengthens its position in China’s cardiovascular drug market with the US$600 million acquisition of Beijing Jialin Pharmaceutical.

Making Driverless Cars A Reality

Making Driverless Cars A Reality

Singapore’s A*STAR and LTA have set up a partnership to propel the development of automated vehicle systems within the country.